-
Morris, SM, Acosta, MT, Garg, S, Green, J, Legius, E, North, K, Payne, JM, Weiss, LA, Constantino, JN, Gutmann, DH.
Autism in neurofibromatosis type 1: misuse of covariance to dismiss autistic trait burden..
Dev Med Child Neurol
63(2)
:
233 -234
2021
view publication
-
Bozaoglu, K, Shern Lee, W, Haebich, KM, North, KN, Payne, JM, Lockhart, PJ.
Generation of four iPSC lines from Neurofibromatosis Type 1 patients..
Stem Cell Res
49:
102013
2020
view publication
-
Payne, JM, Walsh, KS, Pride, NA, Haebich, KM, Maier, A, Chisholm, A, Glad, DM, Casnar, CL, Rouel, M, Lorenzo, J, et al.
Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes..
Dev Med Child Neurol
62(7)
:
813 -819
2020
view publication
-
Efron, D, Taylor, K, Payne, JM, Freeman, JL, Cranswick, N, Mulraney, M, Prakash, C, Lee, KJ, Williams, K.
Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site phase I/II randomised placebo controlled trial..
BMJ Open
10(3)
:
e034362
2020
view publication
-
Ullrich, NJ, Payne, JM, Walsh, KS, Cutter, G, Packer, R, North, K, Rey-Casserly, C, NF Clinical Trials Consortium.
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1..
Ann Clin Transl Neurol
7(2)
:
245 -249
2020
view publication